ArticleMedicine2026
Mendelian randomization analysis reveals a shared protective role of gut microbiota genus Alloprevotella in spontaneous abortion and rheumatoid arthritis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Previous studies to date have demonstrated a significant relationship between spontaneous abortion (SA) and rheumatoid arthritis (RA). Moreover, positive links between gut microbiota and SA, RA have been discussed in observational studies. However, observational studies are prone to bias and result in the causality between gut microbiota and the comorbidity of SA and RA remaining unclear. We therefore aimed to investigate this using a two-sample Mendelian randomization study. A total gut microbiota-related sample size of 18,340 participants from genome-wide association studies was obtained. The summary statistics data for SA (98,453 subjects) and RA (1,53,457 subjects) were obtained from the MRC integrative epidemiology unit genome-wide association studies database as the outcome of gut microbiota. Inverse variance weighted, weighted median, weighted mode, MR-Egger and simple mode were used to assess the causal effects. Sensitivity analyses were applied using the Cochran's Q-statistic, MR-Egger, the leave-one-out analysis, and Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO). In addition, the statistical power was calculated to evaluate the cause-and-effect. We identified genus Alloprevotella as a shared protective factor for both SA (odds ratio [OR] = 0.903, 95% CI: 0.817-0.997, P = .043) and RA (OR = 0.826, 95% CI: 0.722-0.945, P = .005). In addition, increased abundance of genera Actinomyces (OR = 1.213, 95% CI: 1.025-1.435, P = .025), Subdoligranulum (OR = 1.208, 95% CI: 1.036-1.408, P = .016), and Veillonella (OR = 1.167, 95% CI: 1.003-1.358, P = .046) was causally associated with a higher risk of SA. For RA, decreased abundance of genera ChristensenellaceaeR (OR = 0.736, 95% CI: 0.570-0.950, P = .018), Enterorhabdus (OR = 0.806, 95% CI: 0.684-0.950, P = .010), Prevotella7 (OR = 0.895, 95% CI: 0.808-0.991, P = .032) and Hungatella (OR = 0.818, 95% CI: 0.691-0.970, P = .021), along with increased abundance of the Ruminococcus gauvreauii group (OR = 1.406, 95% CI: 1.112-1.777, P = .004), was linked to elevated disease risk. Sensitivity analyses, including MR-PRESSO, MR-Egger, and Cochran's Q-statistic, revealed no evidence of heterogeneity or pleiotropy. Furthermore, leave-one-out analysis confirmed the robustness of the causal estimates. Our study identified several gut microbiota genera with putative causal effects on SA (4 genera) and RA (6 genera). Notably, Alloprevotella emerged as a shared protective factor for both conditions. These findings suggest that gut microbiota, particularly Alloprevotella, may play a causal, protective role in the shared etiology of SA and RA, highlighting a potential common therapeutic target for future research and clinical management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.